There were 247 press releases posted in the last 24 hours and 341,636 in the last 365 days.

Global Meningitis Diagnostic Testing Market Size Estimated to Reach USD 162.62 Million By 2032, at CAGR of 3.5%: Polaris Market Research

NEW YORK, Jan. 25, 2023 /PRNewswire/ -- A latest research report [115+] pages with 360-Degree visibility, titled "Meningitis Diagnostic Testing Market Share, Size, Trends, Industry Analysis Report, By Test Type (Latex Agglutination Test, Lateral Flow Assay, PCR Assay, ELISA Test, Culture Test); By End Use; By Region; Segment Forecast, 2023 - 2032" published by Polaris Market Research in its research repository.

According to recent research study, the global meningitis diagnostic testing market size was valued at USD 115.51 million in 2022 and is expected to reach USD 162.62 Million by 2032, growing at a CAGR of 3.5% during the forecast period.

What is Meningitis Diagnostic Testing? How Big is Meningitis Diagnostic Testing Market Size?

Meningitis is an infection and inflammation of the fluid and the membranes surrounding the brain and spinal cord. These membranes are known as meninges. The rapidly rising demand for the meningitis diagnostic testing market can be attributed to viral infections, one of the most common causes. That is followed by bacterial infections and rarely fungal and parasitic infections. As bacterial infections can lead to death, learning the cause is essential.

The increasing prevalence of meningitis and growing favorable initiatives to battle the disease with appropriate diagnosis and treatment options are anticipated to push market growth during the forecast period. As per the National Organization for Rare Disorders (NORD), in the US, roughly 2,600 people are diagnosed with bacterial meningitis each year.

Request Sample Copy of Meningitis Diagnostic Testing Market Research Report @ https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnostic-testing-market/request-for-sample

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, Table of Contents, Graphical introduction of regional analysis, Top players in the market with their revenue analysis and our research methodology.)

Key data covered in the market report

  • This study aims to determine the market size of several segments and countries with forecast value for the next ten years.
  • Within the region and the countries studied, the report covers both qualitative and quantitative aspects of the industry.
  • It also offers detailed information about important aspects, such as drivers and challenges that will influence the market's future growth.
  • The report will also include investment opportunities in micro markets for stakeholders. In addition, an in-depth analysis of key players' products and competitive landscape.

Our Sample Report May Includes:

  • 2032 Updated Report Introduction, Overview, and In-depth industry analysis.
  • 115+ Pages Research Report (Inclusion of Updated Research).
  • Provide Chapter-wise guidance on Request.
  • 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends.
  • Includes Updated List of table & figures.
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis.

Some of the Top Market Players Are:

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • ELITech Group
  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • Luminex Corporation
  • GlaxoSmithKline
  • Merck KGaA
  • Baxter Quest Diagnostics
  • F. Hoffman-La Roche
  • Cepheid
  • Pfizer

To know an additional revised list of top market players, request a sample report, 2023-2032: https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnostic-testing-market/request-for-sample

Key factors driving market growth

  • Increasing participation of government bodies to regulate outbreaks to push the market

Meningitis diagnostic testing market size is expanding due to the growing participation of government bodies to regulate global meningococcal disorders outbreaks and the surge in demand for rapid diagnostic systems. For instance, in November 2020, WHO, with its international partners occupied in meningitis control and prevention, guided the development of a global road map that sets a direction and vision to combat meningitis by 2030.

Some standard tests used for meningitis diagnosis include PCR tests, ELISA tests, lateral flow assays, culture tests, and other traditional laboratory tests such as total protein tests, CSF tests, and others. Meningitis diagnostic testing market sales are soaring as the development of new, technologically progressive, and precise tests is expected to drive market growth. Some technologically advanced tests are developed with higher sensitivity and swift diagnosis.

Directly Purchase a copy of report with TOC @ https://www.polarismarketresearch.com/checkouts/19421

Recent trends influencing the market

  • Concerns created by typical symptoms of meningitis propel the market

Common symptoms of meningitis are creating worries for both healthcare providers and the general public. Robust diagnostic testing has become the need of the hour. Stakeholders in the EMEA market are escalating the obtainability of products to meet the healthcare needs of individuals.

Transporting samples to laboratories have several logistical challenges in countries falling under the meningitis belt in Africa, as latex agglutination needs refrigeration and lab equipment. Additionally, this technique depends on a sample of spinal fluid from a patient taken by lumber puncture.

Segmentation assessment

  • The PCR assay segment is anticipated to dominate the market

Based on test type, the PCR assay segment is expected to dominate the market. With rapid test results juxtaposed to conventional tests, maximum sensitivity rate, and highly exact and accurate test findings, it has the most significant market revenue. For instance, bacterial meningitis is the chief cause of morbidity and mortality globally. Meningitis diagnostic testing market demand is rising as rapid recognition of meningitis etiological agents is crucial for clinical and public health treatment.

  • The hospital segment is expected to hold a significant revenue share

Based on end use, the hospital segment is expected to hold a significant revenue share. Meningitis diagnostic testing market trends include a large hospital patient pool and call for maximum care delivery. Additionally, those hospitals are equipped with up-to-date diagnostic facilities and a company of qualified doctors, which increases patient availability.

Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnostic-testing-market/inquire-before-buying

(Inquire a report quote OR available discount offers to the sales team before purchase.)

Meningitis Diagnostic Testing Market: Report Scope

Report Attribute

Details

Revenue forecast in 2032

USD 162.62 Million

Market size value in 2023

USD 119.22 Million

Expected CAGR Growth

3.5% from 2023- 2032

Base Year

2022

Forecast Year

2023 – 2032

Top Market Players

Thermo Fisher Scientific, Bio-Rad Laboratories, ELITech Group, Abbott Laboratories, Becton, Dickinson and Company, Luminex Corporation, GlaxoSmithKline, Merck KGaA, Baxter Quest Diagnostics, F. Hoffman-La Roche, Cepheid, and Pfizer

Segments Covered

By Test Type, By End Use, By Region

Customization Options

Customized purchase options are available to meet any research needs. Explore customized purchase options

 

Geographic Overview

  • The growing number of diagnostic centers to drive the North American market

By geography, the market is segmented into North America, Europe, APAC, South America, the Middle East, and Africa. Point-of-care services provide more accurate results in less time compared to traditional methods.

North America held the largest meningitis diagnostic testing market share due to the high adoption rate of modern diagnostic equipment, the growing number of diagnostic centers, the rising number of patients in that region, and the easy obtainability of diagnostic test kits are expected to boost the market. For instance, Florida was suffering a severe ongoing meningococcal illness outbreak, principally among homosexual and bisexual males, including males who were HIV positive, according to an outbreak notification released by the Centre for Disease Control and Prevention.

Browse the Detail Report "Meningitis Diagnostic Testing Market Share, Size, Trends, Industry Analysis Report, By Test Type (Latex Agglutination Test, Lateral Flow Assay, PCR Assay, ELISA Test, Culture Test); By End Use; By Region; Segment Forecast, 2023 - 2032" with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnostic-testing-market

For Additional Information OR Media Enquiry, Please Mail At: sales@polarismarketresearch.com

Polaris Market Research has segmented the meningitis diagnostic testing market report based on test type, end-use, and region:

By Test Type Outlook

  • Latex Agglutination Tests
  • Lateral Flow Assay
  • PCR Assay
  • ELISA Tests
  • Culture Tests

By End Use Outlook

  • Hospitals
  • Diagnostic Centers
  • Others

By Region Outlook

  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Browse More Related Reports:

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

Contact:

Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com 
Follow Us: LinkedIn twitter

Logo: https://mma.prnewswire.com/media/1316207/Polaris_Market_Research_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-meningitis-diagnostic-testing-market-size-estimated-to-reach-usd-162-62-million-by-2032--at-cagr-of-3-5-polaris-market-research-301730474.html

SOURCE Polaris Market Research